Question

Difficulty: MediumDepressive Disorders

A 50-year-old woman is diagnosed with major depressive disorder following a period of persistent low mood and anhedonia. Over the next year, her condition progressively worsens despite various treatment attempts, culminating in a state of severe melancholia characterized by a life-threatening refusal to eat and drink. Arrange the following clinical management steps in the correct chronological sequence, representing a standard stepped-care escalation for this patient's evolving clinical condition.

  1. 1Initiate monotherapy with a selective serotonin reuptake inhibitor (SSRI).
  2. 2Maximize the dosage of the initial SSRI and monitor for an adequate duration.
  3. 3Augment the current regimen with an atypical antipsychotic or switch to a different antidepressant class.
  4. 4Administer electroconvulsive therapy (ECT).

Answer

The correct sequence is to first initiate SSRI monotherapy, then maximize the dosage of that initial agent, followed by augmenting or switching the medication if response remains poor, and finally administering ECT when life-threatening symptoms emerge.
The stepped-care algorithm for major depressive disorder dictates a sequential escalation of therapies based on clinical response. Treatment begins with an initial trial of an SSRI. If the patient has a sub-optimal response, the immediate next step is to maximize the dose of the current medication to ensure an adequate therapeutic trial. Only after failure of an optimized trial should the clinician proceed to augment the regimen (e.g., with an atypical antipsychotic) or switch to a different class. Ultimately, the development of life-threatening complications, such as the refusal to eat and drink leading to severe physiological compromise, is a primary indication for urgently escalating to electroconvulsive therapy (ECT).

Step-by-Step Solution

1
Identify the first-line treatment for a new diagnosis of major depressive disorder.
Initiate SSRI monotherapy.
SSRIs are standard initial therapy due to their favorable side-effect profile and established efficacy.
2
Determine the next step if the initial clinical response is inadequate.
Maximize the dosage of the initial SSRI.
An adequate trial requires optimization of the dose and a sufficient duration (4-8 weeks) before declaring treatment failure.
3
Determine the management for continued non-response or partial response after dose optimization.
Augment the regimen with an atypical antipsychotic or switch classes.
When a maximized first-line agent fails, standard algorithms recommend augmentation strategies or switching to alternative agents like SNRIs or bupropion.
4
Identify the definitive treatment for severe, treatment-resistant depression with life-threatening features.
Administer electroconvulsive therapy (ECT).
ECT provides the most rapid and effective response for severe depression complicated by refusal to eat, catatonia, or acute suicidality.

Key Concept

Stepped-care pharmacological escalation and indications for ECT in Major Depressive Disorder
Estimated Time:1m 0s
Rate this question